Clinical Trial Update: To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to evaluate the efficacy and safety of naxitamab in refractory Ewing sarcoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• Naxitamab (naxitamab)

Snippet

Sponsor: Anna Raciborska | Conditions: Ewing Sarcoma | Phase 2 | Status: RECRUITING